- Home
- CLRB vs LSF Comparison
CLRB vs LSF Comparison
Compare CLRB & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- LSF
- Stock Information
- Founded
- CLRB 2002
- LSF 2015
- Country
- CLRB United States
- LSF United States
- Employees
- CLRB N/A
- LSF N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- LSF Packaged Foods
- Sector
- CLRB Health Care
- LSF Consumer Staples
- Exchange
- CLRB Nasdaq
- LSF Nasdaq
- Market Cap
- CLRB 76.0M
- LSF 90.1M
- IPO Year
- CLRB N/A
- LSF 2020
- Fundamental
- Price
- CLRB $1.86
- LSF $8.56
- Analyst Decision
- CLRB Strong Buy
- LSF Strong Buy
- Analyst Count
- CLRB 2
- LSF 2
- Target Price
- CLRB $21.00
- LSF $7.75
- AVG Volume (30 Days)
- CLRB 289.0K
- LSF 163.5K
- Earning Date
- CLRB 11-18-2024
- LSF 11-06-2024
- Dividend Yield
- CLRB N/A
- LSF N/A
- EPS Growth
- CLRB N/A
- LSF N/A
- EPS
- CLRB N/A
- LSF N/A
- Revenue
- CLRB N/A
- LSF $40,896,326.00
- Revenue This Year
- CLRB N/A
- LSF $21.72
- Revenue Next Year
- CLRB N/A
- LSF $10.16
- P/E Ratio
- CLRB N/A
- LSF N/A
- Revenue Growth
- CLRB N/A
- LSF 20.33
- 52 Week Low
- CLRB $1.82
- LSF $0.71
- 52 Week High
- CLRB $4.45
- LSF $10.35
- Technical
- Relative Strength Index (RSI)
- CLRB 30.70
- LSF 61.10
- Support Level
- CLRB $1.97
- LSF $8.16
- Resistance Level
- CLRB $2.18
- LSF $10.35
- Average True Range (ATR)
- CLRB 0.10
- LSF 0.91
- MACD
- CLRB -0.01
- LSF 0.03
- Stochastic Oscillator
- CLRB 8.11
- LSF 48.57
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.